| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 46.7746 | 36 |
| GSM780708 | Untreated after 4 days (C2_1) | 55.892 | 61 |
| GSM780709 | Untreated after 4 days (C3_1) | 47.5905 | 39 |
| GSM780719 | Untreated after 4 days (C1_2) | 52.8737 | 56 |
| GSM780720 | Untreated after 4 days (C2_2) | 52.7505 | 56 |
| GSM780721 | Untreated after 4 days (C3_2) | 49.7751 | 48 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 47.0998 | 37 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 57.0718 | 62 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 53.8424 | 58 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 46.2948 | 33 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 58.7067 | 63 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 48.9501 | 45 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 53.6162 | 57 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 50.93 | 51 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 47.8931 | 41 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 47.0564 | 37 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 54.3506 | 59 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 52.7175 | 56 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 43.4315 | 19 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 45.1408 | 28 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 47.5062 | 39 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 50.635 | 50 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 48.454 | 43 |